Senior Management Led | Transactions

Histogenics

$9,000,000 Series B Preferred Investment From a Group Led by

Exclusive Placement Agent for Histogenics

More Transactions

Elios

Has Completed a Growth Equity Financing

The undersigned acted as exclusive strategic & financial advisor to ELIOS Vision, Inc.

Has Completed an Oversubscribed Growth Equity Round

The undersigned acted as exclusive strategic & financial advisor to NanoHive Medical, LLC.

Received an equity investment from

The undersigned acted as the exclusive strategic & financial advisor to Innara Health, Inc.

Has sold its business to

The undersigned acted as the exclusive strategic & financial advisor to Verrix, LLC

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    99 High St. Suite 2900, Boston, MA 02110
    (617) 431-2278

© Outcome Capital 2023. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.

Business Continuity Plan | Privacy Policy

Built by Metropolis